89 related articles for article (PubMed ID: 35941213)
1. SRSF2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA Splicing.
Komeno Y; Huang YJ; Qiu J; Lin L; Xu Y; Zhou Y; Chen L; Monterroza DD; Li H; DeKelver RC; Yan M; Fu XD; Zhang DE
Mol Cell Biol; 2015 Sep; 35(17):3071-82. PubMed ID: 26124281
[TBL] [Abstract][Full Text] [Related]
2. Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C.
Skrdlant L; Stark JM; Lin RJ
BMC Mol Biol; 2016 Aug; 17(1):18. PubMed ID: 27552991
[TBL] [Abstract][Full Text] [Related]
3. SRSF2 plays an unexpected role as reader of m
Ma HL; Bizet M; Soares Da Costa C; Murisier F; de Bony EJ; Wang MK; Yoshimi A; Lin KT; Riching KM; Wang X; Beckman JI; Arya S; Droin N; Calonne E; Hassabi B; Zhang QY; Li A; Putmans P; Malbec L; Hubert C; Lan J; Mies F; Yang Y; Solary E; Daniels DL; Gupta YK; Deplus R; Abdel-Wahab O; Yang YG; Fuks F
Mol Cell; 2023 Dec; 83(23):4239-4254.e10. PubMed ID: 38065062
[TBL] [Abstract][Full Text] [Related]
4. Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.
Lee SC; Dvinge H; Kim E; Cho H; Micol JB; Chung YR; Durham BH; Yoshimi A; Kim YJ; Thomas M; Lobry C; Chen CW; Pastore A; Taylor J; Wang X; Krivtsov A; Armstrong SA; Palacino J; Buonamici S; Smith PG; Bradley RK; Abdel-Wahab O
Nat Med; 2016 Jun; 22(6):672-8. PubMed ID: 27135740
[TBL] [Abstract][Full Text] [Related]
5. RUNX1 deficiency cooperates with SRSF2 mutation to induce multilineage hematopoietic defects characteristic of MDS.
Huang YJ; Chen JY; Yan M; Davis AG; Miyauchi S; Chen L; Hao Y; Katz S; Bejar R; Abdel-Wahab O; Fu XD; Zhang DE
Blood Adv; 2022 Dec; 6(23):6078-6092. PubMed ID: 36206200
[TBL] [Abstract][Full Text] [Related]
6. SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.
Kim E; Ilagan JO; Liang Y; Daubner GM; Lee SC; Ramakrishnan A; Li Y; Chung YR; Micol JB; Murphy ME; Cho H; Kim MK; Zebari AS; Aumann S; Park CY; Buonamici S; Smith PG; Deeg HJ; Lobry C; Aifantis I; Modis Y; Allain FH; Halene S; Bradley RK; Abdel-Wahab O
Cancer Cell; 2015 May; 27(5):617-30. PubMed ID: 25965569
[TBL] [Abstract][Full Text] [Related]
7. Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome.
Colla S; Ong DS; Ogoti Y; Marchesini M; Mistry NA; Clise-Dwyer K; Ang SA; Storti P; Viale A; Giuliani N; Ruisaard K; Ganan Gomez I; Bristow CA; Estecio M; Weksberg DC; Ho YW; Hu B; Genovese G; Pettazzoni P; Multani AS; Jiang S; Hua S; Ryan MC; Carugo A; Nezi L; Wei Y; Yang H; D'Anca M; Zhang L; Gaddis S; Gong T; Horner JW; Heffernan TP; Jones P; Cooper LJ; Liang H; Kantarjian H; Wang YA; Chin L; Bueso-Ramos C; Garcia-Manero G; DePinho RA
Cancer Cell; 2015 May; 27(5):644-57. PubMed ID: 25965571
[TBL] [Abstract][Full Text] [Related]
8. A mitochondrial surveillance mechanism activated by
Liu X; Devadiga SA; Stanley RF; Morrow R; Janssen K; Quesnel-Vallières M; Pomp O; Moverley AA; Li C; Skuli N; Carroll MP; Huang J; Wallace DC; Lynch KW; Abdel-Wahab O; Klein PS
bioRxiv; 2024 Apr; ():. PubMed ID: 38712254
[TBL] [Abstract][Full Text] [Related]
9. Cohesin complex mutations in myeloid neoplasms are enriched for SRSF2, RUNX1, TET2, and NRAS co-mutations and morphologic dysplasia.
Hirt CK; Padmanabha N; Michaels PD
Leuk Res; 2023 Sep; 132():107357. PubMed ID: 37481994
[No Abstract] [Full Text] [Related]
10. SRSF2 is required for mRNA splicing during spermatogenesis.
Lei WL; Du Z; Meng TG; Su R; Li YY; Liu W; Sun SM; Liu MY; Hou Y; Zhang CH; Gui Y; Schatten H; Han Z; Liu C; Sun F; Wang ZB; Qian WP; Sun QY
BMC Biol; 2023 Oct; 21(1):231. PubMed ID: 37867192
[TBL] [Abstract][Full Text] [Related]
11. Integrated transcriptome, proteome and single-cell sequencing uncover the prognostic and immunological features of colony-stimulating factor 3 receptor in pan-cancer.
Song L; Jiang F; Tian Y; Cao X; Zhu M; Zhang J; Wang X; Deng L
J Gene Med; 2023 Oct; 25(10):e3508. PubMed ID: 36998239
[TBL] [Abstract][Full Text] [Related]
12. PARP inhibition leads to synthetic lethality with key splicing-factor mutations in myelodysplastic syndromes.
Zhang F; Sun J; Zhang L; Li R; Wang Y; Geng H; Shen C; Li L; Chen L
Br J Cancer; 2024 May; ():. PubMed ID: 38806724
[TBL] [Abstract][Full Text] [Related]
13. Targeting
Su M; Fleischer T; Grosheva I; Horev MB; Olszewska M; Mattioli CC; Barr H; Plotnikov A; Carvalho S; Moskovich Y; Minden MD; Chapal-Ilani N; Wainstein A; Papapetrou EP; Dezorella N; Cheng T; Kaushansky N; Geiger B; Shlush LI
iScience; 2024 Apr; 27(4):109443. PubMed ID: 38558935
[TBL] [Abstract][Full Text] [Related]
14. Altered splicing and intronic polyadenylation of CSF3R via a cryptic exon in acute myeloid leukemia.
Druhan LJ; Lance A; Hamilton A; Steuerwald NM; Tjaden E; Avalos BR
Leuk Res; 2020 Apr; 92():106349. PubMed ID: 32330683
[No Abstract] [Full Text] [Related]
15. Correction to: Morphologic, immunophenotypic, molecular genetic, and clinical characterization in patients with SRSF2-mutated acute myeloid leukemia.
Am J Clin Pathol; 2023 Nov; 160(5):544. PubMed ID: 37748199
[No Abstract] [Full Text] [Related]
16. Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (CSF3R) activity.
Hollander MJ; Malaker SA; Riley NM; Perez I; Abney NM; Gray MA; Maxson JE; Cochran JR; Bertozzi CR
J Biol Chem; 2023 Jun; 299(6):104755. PubMed ID: 37116708
[TBL] [Abstract][Full Text] [Related]
17. Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasms.
Wang BA; Mehta HM; Penumutchu SR; Tolbert BS; Cheng C; Kimmel M; Haferlach T; Maciejewski JP; Corey SJ
Leukemia; 2022 Oct; 36(10):2499-2508. PubMed ID: 35941213
[TBL] [Abstract][Full Text] [Related]
18. Physiological
Kon A; Yamazaki S; Nannya Y; Kataoka K; Ota Y; Nakagawa MM; Yoshida K; Shiozawa Y; Morita M; Yoshizato T; Sanada M; Nakayama M; Koseki H; Nakauchi H; Ogawa S
Blood; 2018 Feb; 131(6):621-635. PubMed ID: 29146882
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
